Myocardial fibrosis (MF) is a key determinant of adverse outcomes in severe aortic stenosis and limits the efficacy of valve implantation. Endomyocardial biopsy is the reference standard for diagnosing MF, but its invasiveness limits routine use. Cardiovascular magnetic resonance (CMR)-derived extracellular volum...
K. Steinhaus, M. Maurer, J. Gronwald et al.· European Heart Journal· 0 citations
Loss of fat-free mass (FFM) is a hallmark of sarcopenia and is associated with adverse outcomes in heart failure (HF). Dual-energy X-ray absorptiometry (DEXA) is considered a reference method for body composition assessment; however, its limited availability and practical constraints, particularly in patients wit...
R. Sato, T. Garfias-Veitl, G. Fibbi et al.· European Heart Journal· 0 citations
Heart failure with preserved ejection fraction (HFpEF) is an increasing public health burden linked to cardiovascular comorbidities. Simple, reliable screening tools are needed to identify high-risk individuals for early detection of cardiac dysfunction and timely treatment. Arterial stiffness commonly coexists w...
J. Gronwald, M. Lange, L. Regent et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.